BCR-ABL1 transcripts (MR4.5) at post-transplant 3 months as an early predictor for long-term outcomes in chronic myeloid leukemia
Sung-Eun Lee, Soo Young Choi, Soo-Hyun Kim, Hye-Young Song, Hea-Lyun Yoo, Mi-Young Lee, Ki-Hoon Kang, Hee-Jeong Hwang, Eun-Jung Jang, Dong-Wook Kim
Korean J Intern Med. 2017;32(1):125-136. Published online 2016 Jun 22 DOI: https://doi.org/10.3904/kjim.2015.187
Citations to this article as recorded by 
Evaluation of Molecular Response to Imatinib Mesylate Treatment in Iranian Patients With Chronic Myeloid Leukemia
Ladan Nekoohesh, Shahrbano Rostami, Mohsen Nikbakht, Saeed Mohammadi, Davood Babakhani, Kamran Alimoghaddam, Mohammad H. Ghahremani, Bahram Chahardouli
Clinical Lymphoma Myeloma and Leukemia.2020; 20(1): e1. CrossRef
A British Society for Haematology Guideline on the diagnosis and management of chronic myeloid leukaemia
Graeme Smith, Jane Apperley, Dragana Milojkovic, Nicholas C. P. Cross, Letizia Foroni, Jenny Byrne, Andy Goringe, Anupama Rao, Jamshid Khorashad, Hugues de Lavallade, Adam J. Mead, Wendy Osborne, Chris Plummer, Gail Jones, Mhairi Copland
British Journal of Haematology.2020; 191(2): 171. CrossRef
Kinome-Wide Screening with Small Interfering RNA Identified Polo-like Kinase 1 as a Key Regulator of Proliferation in Oral Cancer Cells
Yih-Gang Goan, Pei-Feng Liu, Hsueh-Wei Chang, Hung-Chih Chen, Wen-Chi Chen, Shyh-Ming Kuo, Cheng-Hsin Lee, Chih-Wen Shu
Cancers.2019; 11(8): 1117. CrossRef
The role of early molecular predictor in transplant-eligible chronic myelogenous leukemia
Sung-Hyun Kim
The Korean Journal of Internal Medicine.2017; 32(1): 67. CrossRef